| Title |
SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI2 experience
|
|---|---|
| Published in |
Vascular Medicine, February 2017
|
| DOI | 10.1177/1358863x16682863 |
| Pubmed ID | |
| Authors |
Akash Kataruka, Xiaowen Kong, Brian Haymart, Eva Kline-Rogers, Steve Almany, Jay Kozlowski, Gregory D Krol, Scott Kaatz, Michael W McNamara, James B Froehlich, Geoffrey D Barnes |
| Abstract |
A high SAMe-TT2R2 score predicted poor warfarin control and adverse events among atrial fibrillation patients. However, the SAMe-TT2R2 score has not been well validated in venous thromboembolism (VTE) patients. A cohort of 1943 warfarin-treated patients with acute VTE was analyzed to correlate the SAMe-TT2R2 score with time in therapeutic range (TTR) and clinical adverse events. A TTR <60% was more frequent among patients with a high (>2) versus low (0-1) SAMe-TT2R2 score (63.4% vs 52.3%, p<0.0001). A high SAMe-TT2R2 score (>2) correlated with increased overall adverse events (7.9 vs 4.5 overall adverse events/100 patient years, p=0.002), driven primarily by increased recurrent VTE rates (4.2 vs 1.5 recurrent VTE/100 patient years, p=0.0003). The SAMe-TT2R2 score had a modest predictive ability for international normalized ratio (INR) quality and adverse clinical events among warfarin-treated VTE patients. The utility of the SAMe-TT2R2 score to guide clinical decision-making remains to be investigated. |
X Demographics
The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 16 | 37% |
| Spain | 3 | 7% |
| Mexico | 2 | 5% |
| Ecuador | 1 | 2% |
| Costa Rica | 1 | 2% |
| Canada | 1 | 2% |
| Malaysia | 1 | 2% |
| Saudi Arabia | 1 | 2% |
| United Kingdom | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 16 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 24 | 56% |
| Practitioners (doctors, other healthcare professionals) | 12 | 28% |
| Scientists | 5 | 12% |
| Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 6% |
| Unknown | 15 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 4 | 25% |
| Student > Master | 3 | 19% |
| Researcher | 2 | 13% |
| Other | 2 | 13% |
| Student > Doctoral Student | 1 | 6% |
| Other | 1 | 6% |
| Unknown | 3 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 44% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 13% |
| Unspecified | 1 | 6% |
| Agricultural and Biological Sciences | 1 | 6% |
| Nursing and Health Professions | 1 | 6% |
| Other | 0 | 0% |
| Unknown | 4 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2019.
All research outputs
#1,443,932
of 24,940,046 outputs
Outputs from Vascular Medicine
#53
of 1,113 outputs
Outputs of similar age
#30,792
of 430,875 outputs
Outputs of similar age from Vascular Medicine
#2
of 19 outputs
Altmetric has tracked 24,940,046 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,113 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,875 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.